Kits are despatched within 5-7 days of purchase date. The delivery time for your kit will vary depending on the postal service you have selected. Once you receive your kit, follow the simple instructions to activate it and send us your DNA sample. If you’re a new or returning Findmypast customer, you’ll receive a complimentary 14-day Findmypast subscription when you activate your kit.
Similarly, mitochondrial DNA, or mtDNA, is used by direct-to-consumer DNA tests to trace your direct maternal lineage and determine maternal haplogroups. While most DNA lives in your cells' nuclei, mtDNA lives in the mitochondria. Mitochondria are the cells' powerhouses – their 37 genes are necessary for cellular energy production and respiration. Previous research suggested that mtDNA is inherited directly from your mother, but a recent study found that biparental mtDNA may be more common. This discovery may affect maternal haplogroup testing in DNA tests in the future, but for now, it’s safe to assume your results are correct.
To prepare to take a cheek swab sample, you also have to refrain from eating for about an hour before. Swab kits generally contain more components, including one or two swabs and containers to protect the used swabs from contamination. We found it easiest to organize all the pieces first, to prevent any fumbling with a sample collection swab in hand. Some cheek cell kits put a stabilizing liquid in the sample containers, which required extra caution to prevent spilling.
While men can trace both their maternal haplogroup (from mitochondrial DNA) and their paternal haplogroup (through the Y chromosome passed down from their father), women can only trace their maternal haplogroup (through the mitochondrial DNA passed down from their mother). This is because the paternal haplogroup is traced through the Y chromosome, which women do not inherit.
EasyDNA specialises in paternity testing. Results provide 100% accuracy if the male tested is not the biological father of the child and a 99.99% probability if he is the biological. We also offer a wide range other tests including DNA Profiles, DNA Art, Twin Zygosity DNA Testing, Forensic DNA Testing, Genetic Predisposition Test and Ancestry DNA Testing. Our many relationship tests will help determine whether alleged relatives, such as siblings or grandparents and their grandchildren, are truly biologically related.
For our evaluations, we assembled a group of testers willing to spit into a tube on camera. We chose four individuals of varying backgrounds. Two had previously taken one or more DNA ancestry tests, and two had not. Two had fairly well-documented family histories to compare against, one was adopted, and one had information about one side of the family, but not the other. All of us took DNA tests from AncestryDNA, 23andMe, National Geographic and Family Tree DNA. One tester also took each of the five additional tests we reviewed. After collecting spit and cheek cells, we mailed all of the tests at the same time and waited for results, noting all communications from the company in the meantime and how long it took each service to notify us that results were ready to view. We collected data based on testers’ impressions of their results, each service’s features and extras, how easy it was to use and navigate the service’s website, along with several other factors. We added this testing data to rigorous research and information gleaned from conversations with representatives from Ancestry, 23andMe, MyHeritageDNA, LivingDNA, Humancode (now owned by Helix) and 24genetics.
Molly K. McLaughlin is a New York-based writer and editor with more than a decade of experience covering technology. She has tested and reviewed all sorts of software, mobile apps, and gadgets. Before launching her freelance business, she was an editor at PC Magazine, covering consumer electronics, followed by a stint at ConsumerSearch.com, a revie... See Full Bio
In Newman’s view, the genie is out of the bottle with home genetic-testing kits. He says that while the kits could potentially provide data in the future, right now, they lack “clinical utility” – they look at genetic variants that, individually, have a very low chance of predicting specific health risks, as there are too many variables: “It’s like the Opportunity Knocks clap-o-meter, with some people further along the scale, and therefore more likely to get the condition and then people at the other end of the scale, who are unlikely to get it.”